Matthew Plavan
2019 - Arcadia Biosciences
In 2019, Matthew Plavan earned a total compensation of $581.1K as President and Chief Executive Officer at Arcadia Biosciences, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,500 |
|---|---|
| Option Awards | $105,040 |
| Salary | $321,538 |
| Total | $581,078 |
Plavan received $321.5K in salary, accounting for 55% of the total pay in 2019.
Plavan also received $154.5K in non-equity incentive plan and $105K in option awards.
Rankings
In 2019, Matthew Plavan's compensation ranked 11,302nd out of 13,971 executives tracked by ExecPay. In other words, Plavan earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,302 out of 13,971 | 19th |
Division Agriculture, Forestry, And Fishing | 36 out of 48 | 25th |
Major group Agricultural Production Crops | 20 out of 30 | 33rd |
Source: SEC filing on April 17, 2020.
Plavan's colleagues
We found four more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2019.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019